U.S. legislative proposals requesting the National Academies study feasibility and benefits of delinking pharmaceutical innovation from drug prices KEI Briefing Note 2026:3 May 4, 2026 Zazie Huml KEI-BN-2026-3 Several members of Congress have asked the U.S. National Academies to study… Continue Reading →
On Saturday, 27 January 2024, Knowledge Ecology International (KEI) delivered the following statement on the recommendations of the independent WHO Council on the Economics of Health for All. EB 154: KEI statement on Economics and health for all KEI read… Continue Reading →
On Wednesday, 24 January 2024, Knowledge Ecology International (KEI) delivered the following statement on Universal Health Coverage. In order to achieve universal health coverage with access to medicine for all, governments need to de-link the incentives to invest in R&D… Continue Reading →
On Monday, 22 January 2024, Knowledge Ecology International (KEI) delivered the following statement at the 154th session of the World Health Organization’s (WHO) Executive Board on the Draft fourteenth general programme of work. EB 154: KEI statement on the Draft… Continue Reading →
These are the slides that were used in a KEI-People’s Vaccine Alliance webinar on delinking R&D financing from temporary monopolies. KEI-PVA-webinar-Delinking-rnd-5oct2023
On 1 September 2023, Csaba Kőrösi, President of the 77th United Nations General Assembly, circulated three draft texts of political declarations related to the following processes: High-level meeting on pandemic prevention, preparedness and response(resolution77/275) High-level meeting on universal health coverage… Continue Reading →
Update: S.2333 passed Senate HELP today on a 17-3 bipartisan vote, with the delinkage study included. On Thursday, July 20, 2023, the Senate HELP Committee will consider a bill to reauthorize the Pandemic and All-Hazards Preparedness and Response Act (PAHPA).… Continue Reading →
On Saturday, 29 January 2022,Knowledge Ecology International (KEI) delivered the following statement on the Global strategy and plan of action on public health, innovation and intellectual property at the 150th session of the World Health Organization’s Executive Board. Access to… Continue Reading →
Below is a link to an essay on the use of the phrase “global public goods”. The essay focuses on the three papers Paul Samuelson wrote in the 1950s that are often used, and misused, to define public goods. Samuelson’s… Continue Reading →
KEI is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the 73rd World Health Assembly. https://extranet.who.int/nonstateactorsstatements/meetingoutline/6 Knowledge Ecology International Meeting: Seventy-third World Health Assembly Written statements on COVID-19 pandemic The biggest question today… Continue Reading →